Tolerability Issues : The adverse events with the GLP-1-based therapies are primarily gastrointestinal and include nausea, vomiting, constipation, or diarrhea [82], leading to meaningful discontinuation rates that limit real-world effectiveness
B12 SUPPORT WHEN YOU NEED IT
Injection site reactions Redness, itching, swelling, and minor bruising occur in approximately 1.4% of semaglutide users and 2.4% of tirzepatide users
Aim: to compare QoL in adult HAE-C1-INH patients younger and older than 65 years
[10] [11] It is important to check folate status alongside B12, but folate supplementation should not be started before excluding B12 deficiency, as this may precipitate neurological complications
Eat it slowly and enjoy it without multitasking